hemovigilance & blood banking
TRANSCRIPT
Hemovigilance & Blood Banking
Dr. M.Edalati
Ph.D. of Hematology and Blood Banking
Hemovigilance
تعریف
جمغ و سيستماتيك صورت به تشریق اس ناشی ػوارض گشارش-1 واحد یك در آوري
اثزات به مزبوط هاي داده تحليل و تجشیه و گزدآوري- 2
اخذ و تصحيح منظور به خطز اػلام و خون انتقال ناخواسته آنها مجدد وقوع اس جلوگيزي بزاي لاسم اصلاحی اقدامات
بزرسی و بيمارستان یك در خون تشریق موارد ساسي مستند - 3 متوالی هاي سال در آن اي مقایسه
ها بيمارستان در خون تشریق ارتقاي و هدایت - 4
:یک واحد خون کامل
RBC (1 FFP (2
(3 CP Plt (4
IG , Alb plasma
Packed red blood cells
(RBC)
از %۲۰ حدود شده شسته قرمز گلبول فرآوردۀ در
به نزدیک و سفید گلبولهای از %۸۵ ، قرمز گلبولهای .یابد می کاهش اولیه پلاسمای از ۹۹%
Fresh Frozen Plasma
(FFP)
Cryo precipitate
VIIIفاکتور
واحد بین المللی 80-120میزان به
فیبرینوژن 150 -300mg
VWF
مقدار اولیه% 40-%70به میزان
XIII فاکتور
اولیه مقدار % 20 -% 30میزان به
فیبرونکتینمقادیر قابل توجهی
Platelet
Whole blood
مثلث مرگ
نمونه گیری
تزریق بانک خون
فرم ها
BLood Banking
ABO DISCREPANCIES & OTHER
PROBLEMS
DISCREPANCIES
A discrepancy occurs when the red cell testing
does NOT match the serum testing results
In other words, the forward does NOT match
the reverse
WHY?
Reaction strengths could be weaker than
expected
Some reactions may be missing in the reverse
or forward typings
Extra reactions may occur
Patient Anti-A Anti-B A1 Cells B Cells
1 4+ 1+ 0 4+
2 0 4+ 1+ 0
3 4+ 4+ 1+ 0
4 0 3+ 0 0
WHAT DO YOU DO?
Identify the problem
Most of the time, the problem is technical
Mislabeled tube
Failure to add reagent
Either repeat test on same sample, request a new sample, or wash cells
Other times, there is a real discrepancy due to problems with the patient’s red cells or serum
TECHNICAL ERRORS
Clerical errors Mislabeled tubes
Patient misidentification
Inaccurate interpretations recorded
Computer entry error
Reagent or equipment problems Using expired reagents
Using an uncalibrated centrifuge
Contaminated or hemolyzed reagents
Incorrect storage temperatures
Procedural errors Reagents not added
Manufacturer’s directions not followed
RBC suspensions incorrect concentration
Cell buttons not resuspended before grading agglutination
CONTAMINATED SAMPLES OR REAGENTS
Sample contamination
Microbial growth in tube
Reagent contamination
Bacterial growth causes cloudy or discolored
appearance…do not use if you see this!
Reagents contaminated with other reagents (don’t
touch side of tube when dispensing)
Saline should be changed regularly
HEMOLYSIS
Detected in serum after centrifugation (red)
Important if not documented
Can result from:
Complement binding
Anti-A, anti-B, anti-H, and anti-Lea
Bacterial contamination
Red
supernatant
ABO DISCREPANCIES
ABO DISCREPANCIES
Problems with RBCs
Weak-reacting/Missing antigens
Extra antigens
Mixed field reactions
Problems with SERUM
Weak-reacting/Missing antibodies
Extra antibodies
Grouping
Forward Reverse
Missing/Weak Extra Mixed Field Missing/Weak Extra
A/B Subgroup
Disease
(cancer)
Acquired B
B(A) Phenotype
O Transfusion
Bone Marrow
Transplant
Young
Elderly Immunocompromised
Cold
Autoantibody
Anti-A1
Rouleaux
Cold
Alloantibody
Rouleaux
May cause all + reactions
Forward Grouping Problems
Red Cell Problems
• Affect the forward grouping results
– Missing or weak antigens
– Extra antigens
– Mixed field reactions
Forward Grouping:
Missing or Weak antigens
Anti-A Anti-B A1 Cells B Cells
0 0 0 4+
• ABO Subgroups
• Disease (leukemia, Hodgkin’s disease)
• Since the forward and reverse don’t match, there must be a discrepancy (in this case, a missing antigen in the forward grouping)
Group O Group A
Subgroups of A (or B)
• Subgroups of A account for a small portion of the A population (B subgroups rare)
• These subgroups have less antigen sites on the surface of the red blood cell
• As a result, they show weakened (or missing) reactions when tested with commercial antisera
• Resolution: test with Anti-A1, Anti-H, and anti-A,B for A subgroups
Forward Grouping:
Extra Antigens
Anti-A Anti-B A1
Cells
B
Cells
4+ 1+ 0 4+
• Acquired B
• B(A) phenotype
• Rouleaux
• Polyagglutination
• Wharton’s Jelly
EXAMPLE
Acquired B Phenotype
• Limited mainly to Group A1 individuals with:
– Lower GI tract disease
– Cancer of colon/rectum
– Intestinal obstruction
– Gram negative septicemia (i.e. E. coli)
Acquired B
• Bacteria (E. coli) have a deacetylating enzyme that effects the A sugar….
Group A individual
N-acetyl galactosamine
Acquired B Phenotype
Bacterial enzyme removes acetyl group
Galactosamine now resembles D-
galactose (found in Group B)
Resolving Acquired B
• Check patient diagnosis: Infection?
• Some manufacturers produce anti-B reagent that does not react with acquired B
• Test patients serum with their own RBCs
– The patients own anti-B will not react with the acquired B antigen on their red cell (autologous testing)
B(A) phenotype
• Similar to acquired B
• Patient is Group B with an apparent extra A antigen
• The B gene transfers small amounts of the A sugar to the H antigen
• Sometimes certain anti-A reagents will detect these trace amount of A antigen
• Resolution: test with another anti-A reagent from another manufacturer
Other reasons for “extra” antigens
• Polyagglutination – agglutination of RBCs with human antisera no matter what blood type – Due to bacterial infections
– Expression of hidden T antigens react with antisera
• Rouleaux – extra serum proteins
• Wharton’s Jelly – gelatinous substance derived from connective tissue that is found in cord blood and may cause false agglutination (Remember: only forward typing is performed on cord blood) – Wash red cells or request new sample from heel, etc
Forward Grouping:
Mixed Field Agglutination
Anti-A Anti-B A1 Cells B Cells
0 2+ mf 4+ 0
• Results from two different cell populations
• Agglutinates are seen with a background of unagglutinated cells
– All groups transfused with Group O cells
– Bone marrow/stem cell recipients
– A3 phenotype (sometimes B3)
Mixed Field Agglutination (Post transfusion) ~ (ABO Testing) Can be seen in A, B and AB individuals who have received O units. The antisera reacts with the patient’s RBCs, but not with the transfused O cells.
~ (Antibody screen) Can also be seen post transfusion if a person makes an antibody to antigen on donor cells; antibody agglutinates with donor cell, but not their on cells.
Reverse Grouping Problems
Reverse Grouping
• Affect the reverse grouping results
– Missing or weak antibodies
– Extra antibodies
Reverse Grouping:
Missing or Weak antibodies
• Newborns – Do not form antibodies until later
• Elderly – Weakened antibody activity
• Hypogammaglobulinemia – Little or no antibody production (i.e.
immunocompromised)
• Often shows NO agglutination on reverse groupings
Resolving Weak or Missing antibodies
• Determine patients age, diagnosis
• Incubate serum testing for 15 minutes (RT) to enhance antibody reactions
• If negative, place serum testing at 4°C for 5 minutes with autologous control (a.k.a. Autocontrol, AC)
• This is called a “mini-cold” panel and should enhance the reactivity of the antibodies
Reverse Grouping:
Extra Antibodies
• Cold antibodies (allo- or auto-)
– Cold antibodies may include anti-I, H, M, N, P, Lewis
• Rouleaux
• Anti-A1 in an A2 or A2B individual
Cold antibodies
• Sometimes a patient will develop cold-reacting allo- or auto-antibodies that appear as “extra” antibodies on reverse typing
• Alloantibodies are made against foreign red cells
• Autoantibodies are made against ones own red cells. Cold reacting antibodies cause agglutination with red cells at room temperature and below. The autocontrol will be positive. – Resolution: warming tube to 37° and washing red cells
can disperse agglutination; breaking the IgM bonds with 2-ME will also disperse cells
Cold agglutinins
RBC-Histogram Results
RBC
HGB
HCT
MCV
MCH
MCHC
RDW
2.23 x1012/L
14.4g/dl
24.9%
111.7fl
64.6pg
57.8g/dl
25.4fl
(x 1000)
Results RBC-Histogram
RBC
HGB
HCT
MCV
MCH
MCHC
RDW
4.35 x1012/L
14.5g/dl
43.5%
100.0fl
33.3pg
33.3g/dl
14.7fl
Incubation 30 min
(x 1000)
Rouleaux
• Can cause both extra antigens and extra antibodies • “stack of coins” appearance • May falsely appear as agglutination due to the
increase of serum proteins (globulins) • Stronger at IS and weak reaction at 37°C and no
agglutination at AHG phase • Associated with:
– Multiple meloma – Waldenstrom’s macroglobulinemia (WM) – Hydroxyethyl starch (HES), dextran, etc
Resolving Rouleaux
• Remove proteins! • If the forward grouping is affected, wash cells to
remove protein and repeat test • If the reverse grouping is affected, perform saline
replacement technique (more common) – Cells (reagent) and serum (patient) centrifuged to allow
antigen and antibody to react (if present) – Serum is removed and replaced by an equal volume of
saline (saline disperses cells)* – Tube is mixed, centrifuged, and reexamined for
agglutination (macro and micro) *some procedures suggest only 2 drops of saline (UMMC)
True Rouleaux
True Rouleaux
most of the red cells, in the proper viewing area, are stacked together like coins.
Four or more cells make up each formation, leaving much of the field empty of cells (increased white space).
Rouleaux is clinically significant when increased globulins are present, as in multiple myeloma.
False rouleaux
True rouleaux
Artifactual
Autoagglutination
• Cells clumping
together rather than
stacked like coins.
• Autoagglutination is
caused by the
presence of antibody
in the plasma.
Anti-A1
• Sometimes A2 (or A2B) individuals will develop an anti-A1 antibody
• A2 (or A2B) individuals have less antigen sites than A1 individuals
• The antibody is a naturally occurring IgM
• Reacts with A1 Cells, but not A2 Cells
Anti-A1 from patient
+ A1 cells
+ A2 cells
AGGLUTINATION
NO AGGLUTINATION
Resolving anti-A1 discrepancy
Anti-A Anti-B A1
Cells
B
Cells
4+ 0 2+ 4+
• 2 steps:
– Typing patient RBCs with Anti-A1 lectin
– Repeat reverse grouping with A2 Cells instead of A1 Cells
– Both results should yield NO agglutination
Others…
• The Bombay phenotype (extremely RARE) results when hh is inherited
• These individuals do not have any antigens and naturally produce, anti-A, anti-B, anti-A,B, and anti-H
• Basically, NO forward reaction and POSITIVE reverse
• Resolution: test with anti-H lectin (Bombay’s don’t have H and will not react)
Resolving ABO Discrepancies
• Get the patient’s history:
– age
– Recent transplant
– Recent transfusion
– Patient medications
….
Agglutination
Passive Agglutination/Hemagglutination
• Definition - agglutination test done with a soluble antigen coated onto a particle
+
• Applications
– Measurement of antibodies to soluble antigens
Coombs (Antiglobulin)Tests
• Incomplete Ab • Direct Coombs Test
– Detects antibodies on erythrocytes
+
Patient’s RBCs Coombs Reagent (Antiglobulin)
Coombs (Antiglobulin)Tests
• Indirect Coombs Test
– Detects anti-erythrocyte antibodies in serum
Patient’s Serum
Target RBCs
+ Step 1
+
Coombs Reagent (Antiglobulin)
Step 2
Coombs (Antiglobulin)Tests
• Applications
– Detection of anti-Rh Ab
– Autoimmune hemolytic anemia
Agglutination/Hemagglutination Inhibition
• Definition - test based on the inhibition of agglutination due to competition with a soluble Ag
+
Prior to Test
+ +
Test
Patient’s sample
Let’s practice !
Example 1
Anti-A Anti-B A1 Cells B Cells
3+ 0 0 1+
Problem:
Causes:
Resolution:
Example 2
Anti-A Anti-B A1 Cells B Cells
3+ 1+ 0 4+
Problem:
Causes:
Resolution:
Example 3
Anti-A Anti-B A1 Cells B Cells
2+ 0+ 1+ 4+
Problem:
Causes:
Resolution:
Example 4
Anti-A Anti-B A1 Cells B Cells
0 0 0 3+
Problem:
Causes:
Resolution:
Example 5
Anti-A Anti-B A1 Cells B Cells
0 2+mf 3+ 0
Problem:
Causes:
Resolution:
Example 6
Anti-A Anti-B A1 Cells B Cells
4+ 4+ 0 1+
Problem:
Causes:
Resolution:
Example 7
Anti-A Anti-B A1 Cells B Cells
0 0 0 0
Problem:
Causes:
Resolution:
Thanks